Therefore, the accurate identification of adult patients who require IVIG therapy is a clinically important issue [49]
If glutathione (GSH) levels are low, these toxins are not efficiently removed from the body and can cause damage to cellular DNA, cell membranes, and mitochondria, which can result in an array of symptoms and disease, contribute to existing medical conditions (such as infertility), and cause problems with pregnancy and the future health of the offspring
A 2020 meta-analysis of 37 randomized trials found an average body-weight reduction of 1.21 kg, with the clearest dose-response signal around 2,000 mg per day
Retest after each adjustment
Given the above and current knowledge, a clinically significant DDI between GLP1RAs and COCs is probably not expected, and there is no recommendation in any GLP1RA prescription sheet for dose adjustment of COCs in this context